Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

IRP’s Anthony Fauci Talks COVID-19 With Stephen Curry

Infectious Disease Expert Interviewed by NBA Superstar

By Brandon Levy

Wednesday, April 1, 2020

As the COVID-19 illness has continued to spread, so has anxiety, fear, and uncertainty. Now more than ever, we need communicators who can provide clear explanations about the latest research and public health guidelines.

IRP senior investigator Anthony Fauci, Ph.D., has been one of the most prominent voices providing information about the novel coronavirus over the past several weeks. Dr. Fauci, who serves as director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), seems to be doing everything he can to make sure the American public has the best information available about the current situation, from speaking at White House press briefings to appearing on television shows like The Daily Show with Trevor Noah. Last Thursday, March 26, Dr. Fauci participated in a live Q&A with NBA superstar Stephen Curry on Curry’s Instagram page. Read on for a few highlights from their discussion, or click on the video below to watch the entire conversation.

Basketball superstar Stephen Curry (left) chatted with the IRP’s Anthony Fauci (right) about COVID-19 on Instagram Live on March 26.

On the differences between the novel coronavirus and the seasonal flu

“It’s very, very much more transmissible than flu, and more importantly, it’s significantly more serious…The overall mortality of seasonal flu that you and I confront every year is about 0.1 percent. The overall mortality of coronavirus is about 1 percent, and sometimes — like in China — it was up to 2 or 3 percent, which means it’s 10 times more serious than the typical influenza. So when people kind of compare it, in some respects it has some similarities, but it’s really, really different in its degree of seriousness.”

On whether contracting the novel coronavirus confers immunity to future infections by the same illness

“We haven’t done the specific testing to determine that, but if this acts like every virus similar to it that we know, the chances are overwhelming that if you get infected [and] recover from infection, that you are not going to get reinfected with the same virus, which means you can then safely go out into the community and feel immune so that you can not only protect yourself, get back to work, get back to your job, but you’ll also be able to have what you refer to as ‘herd immunity.’ [When] enough people [have] recovered in a community, that gives the virus very little chance to spread rapidly.”

This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S.

On how the changing seasons could affect the transmission of COVID-19

“Viruses tend to do poorly in warm, moist weather and do quite well in cold, dry weather, and that’s one of the reasons why — in addition to the fact that in the warm weather you’re more outside and not confined in a room — that these kinds of respiratory viruses tend to go down as you get to the summer months…We don’t know whether this is going to happen with this virus because this is the first time we’ve ever dealt with this virus, so it’s not an unreasonable assumption to think that it’s going to go down, but you don’t want to count on it.”

On our ability to more effectively contain the virus if it re-emerges in the fall after a summer hiatus

“I think and I hope — and it’s not just hope because I think, if we do it right, it will happen this way — that we will get enough experience so that, when it does come back, we will be able to immediately identify, isolate, and contact-trace. And if you do that effectively, you don’t have an outbreak. You contain it at a very low level, which would mean we won’t have to lock down again…It will be much different than what we’re doing right now.”

On how long it will take to develop a COVID-19 vaccine

“We have started on the development of a vaccine faster than ever in the history of any virus, from the time [the virus] was discovered to the time that we made [the vaccine] and put it into a trial. But when you test a vaccine, it’s multiple phases. The first thing you’ve got to do is make sure it’s safe. We started that a couple weeks ago. When you find out it’s safe and that it induces the kind of response you want it to, then you do it in a lot of people. The first stage you have to be careful — it’s like 45 people. Then you go into hundreds, if not thousands, of people in what’s called a phase 2/3 trial to determine if it works…If we really push, we hope that we will know by the time we get into next winter whether or not we have something that works.”

On the biggest misconception about COVID-19 that Dr. Fauci has encountered

“This dichotomy between people who are being frightened to death of [COVID-19] versus people who don’t even believe it and think it’s something trivial that you don’t have to worry about. I’d like to get the people in the country to realize that we are dealing with a serious problem…We’ve modified our lives. It’s not convenient to lock yourself in…but we’re going through a period of time now where we’ve got to — as a country — pull together, don’t get frightened, don’t get intimidated, use the energy to be able to confront it and do the kinds of things that will put an end to it. I want to get rid of that misconception that there’s extremes: either the world is going to end, or we don’t want to do anything. It isn’t that. It’s somewhere in the middle.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.


Category: Science
Tags: coronavirus, COVID-19, public health, vaccines, infectious disease, virus, flu, influenza, immune system, communication

Related Blog Posts

  • Leading the Charge Against Infectious Disease
  • Pandemic Brings All Hands on Deck
  • IRP Researchers Tackle Coronavirus Crisis
  • IRP Pushes Forward in Fight Against Pandemic Virus
  • Study Explores Sex Differences in Flu

This page was last updated on Friday, March 11, 2022

Blog menu

  • Contributing Authors
    • Alison Jane Martingano
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Dianne Lee
    • Gabrielle Barr
    • Melissa Glim
    • Michele Lyons
  • Categories
    • Collaboration
    • Science
    • Resources
    • Making a Difference
    • Careers

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search